Antithrombin therapy in pancreas retransplantation and pancreas-after-kidney/pancreas-transplantation-alone patients

Clinical Transplantation

Volumn 25, Issue 5, 2011, Pages

  Fertmann, Jan M ^a   Arbogast, Helmut P ^a   Illner, Wolf Dieter ^a   Tarabichi, Anwar ^a   Dieterle, Christoph ^b   Land, Walter ^a   Jauch, Karl Walter ^a   Hoffmann, Johannes N ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antithrombin; Graft pancreatitis; Ischemia reperfusion injury; Pancreas after kidney transplantation; Pancreas retransplantation; Pancreas transplantation alone; Solitary pancreas transplantation

Indexed keywords

AMYLASE; ANTITHROMBIN; TRIACYLGLYCEROL LIPASE;

ADULT; AMYLASE BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; HUMAN; ISCHEMIA; KIDNEY PANCREAS TRANSPLANTATION; PANCREAS TRANSPLANTATION; PARTIAL THROMBOPLASTIN TIME; PILOT STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; RETRANSPLANTATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THROMBOPLASTIN TIME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; AGED; ANTITHROMBINS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; REOPERATION; REPERFUSION INJURY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054098785     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01472.x     Document Type: Article

References (32)

1. Reddy KS, Stratta RJ, Shokouh-Amiri MH, Alloway R, Egidi MF, Gaber AO. Surgical complications after pancreas transplantation with portal-enteric drainage. J Am Coll Surg 1999: 189: 305.
2. Rogers J, Chavin KD, Baliga PK et al. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg 2003: 7: 1096.
3. Spiros D, Christos D, John B, Burke GW, Miller J, Ciancio G. Vascular complications of pancreas transplantation. Pancreas 2004: 28: 413.
4. Fellmer P, Lanzenberger K, Ulrich F et al. Complication rate of pancreas retransplantation after simultaneous pancreas-kidney transplantation compared with pancreas after kidney transplantation. Transplant Proc 2007: 39: 563.
5. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005: 19: 433.
6. Maraschio MA, Kayler RM, Merion RM et al. Successful surgical salvage of partial pancreatic allograft thrombosis. Transplant Proc 2003: 35: 1491.
7. Gruessner RW, Sutherland DE, Troppmann C, Benedetti E, Hakim E, Dunn DL. The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg 1997: 185: 128.
8. Burke GW, Ciancio G, Figueiro J et al. Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy. Clin Transplant 2004: 18: 423.
9. Schaser K-D, Puhl G, Vollmar B et al. In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation. Am J Transplant 2005: 5: 341.
10. Hoffmann JN, Muehlbayer D, Jochum M, Inthorn D. Effect of long-term and highdose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis. Crit Care Med 2004: 32: 1851.
11. ÖZden A, Sarioglu A, Demirkan NC, Bilihan A, Düzcan E. Antithrombin III reduces renal ischemia-reperfusion injury in rats. Res Exp Med 2001: 200: 195.
12. Ostrovsky L, Woodman R, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997: 96: 2302.
13. Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 1999: 93: 157.
14. Langley PG, Hughes RD, Forbes A, Keays R, Williams R. Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol 1993: 17: 326.
15. Hackert T, Werner J, Uhl W, Gebhard M-M, Bücheler MW, Schmidt J. Reduction of ischemia/reperfusion injury by antithrombin III after experimental pancreas transplantation. Am J Surg 2005: 189: 92.
16. Cowan PJ, Aminian A, Barlow H et al. Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transplant 2002: 2: 520.
17. Aramaki O, Takayama T, Yokoyama T et al. High dose of AT induces indefinite survival of fully allogenic cardiac grafts and generates regulatory cells. Transplantation 2003: 75: 217.
18. Fertmann JM, Wimmer CD, Arbogast HP et al. Single-shot antithrombin in human pancreas-kidney transplantation: reduction of reperfusion pancreatitis and prevention of graft thrombosis. Transpl Int 2006: 19: 458.
19. Hoffmann JN, Arbogast HP, Fertmann J et al. High dose antithrombin therapy reduces ischemia/reperfusion injury during human allogenic kidney transplantation: first results of a randomized controlled trial. Transplantation 2002: 74: 394.
20. Inthorn D, Hoffmann JN, Hartl WH, Muhlbayer D, Jochum M. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock 1998: 10: 90.
21. Inthorn D, Hoffmann JN, Hartl WH, Muhlbayer D, Jochum M. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction. Shock 1997: 8: 328.
22. Hoffmann JN, Wiedermann CJ, Juers M et al. Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin. Thromb Haemost 2006: 95: 850.
23. Hoffmann JN, Vollmar B, Laschke MW et al. Adverse effects of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 2002: 88: 242.
24. Pulletz S, Lehmann C, Volk T et al. Influence of heparin and hirudin on endothelial binding of antithrombin in experimental thrombinemia. Crit Care Med 2000: 28: 2881.
25. Opal SM, Kessler CM, Roemisch J et al. Antithrombin, heparin and heparane sulfate. Crit Care Med 2002: 30(Suppl): S325.
26. Sorg H, Hoffmann JN, Menger MD, Lindenblatt N, Goehring P, Vollmar B. Antithrombin is as effective as heparin and hirudin to prevent formation of microvascular thrombosis in a murine model. Thromb Haemost 2006: 96: 371.
27. Hoffmann JN, Vollmar B, Laschke MW, Fertmann JM, Jauch K-W, Menger MD. Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition. Crit Care 2005: 9(Suppl 4): S33.
28. Secchi A, Malaise J, Caldara R, the Euro-SPK Study Group. Metabolic results 3years after simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2005: 20(Suppl 2): ii18.
29. Burke GW, Ciancio G, Cirocco R et al. Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. Transplantation 1999: 68: 1336.
30. Suehiro A, Sawada A, Hasegawa Y, Takatsuka H, Higasa S, Kakishita E. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation. Bone Marrow Transplant 2002: 29: 107.
31. Humar A, Ramcharan T, Kandaswamy R, Gruessner RWG, Gruessner C, Sutherland DER. Technical failures after pancreas transplants: why grafts fail and the risk factors - a multivariate analysis. Transplantation 2004: 78: 1188.
32. Stratta RJ, Alloway RR, Lo A, Hodge EE, for the PIVOT study group. Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation? Transplant Proc 2004: 36: 1076.